Page last updated: 2024-08-22

nimorazole and Local Neoplasm Recurrence

nimorazole has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andersen, M; Eriksen, JG; Hansen, CR; Jensen, K; Overgaard, J; Saksø, M	1

Trials

1 trial(s) available for nimorazole and Local Neoplasm Recurrence

Article	Year
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, lary Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 148 Topics: Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Feasibility Studies; Head and Neck Neoplasms; Humans; Hypopharynx; Larynx; Middle Aged; Mouth; Neoplasm Recurrence, Local; Nimorazole; Oropharynx; Papillomavirus Infections	2020

Article

Year

DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, lary

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 148

Topics: Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Feasibility Studies; Head and Neck Neoplasms; Humans; Hypopharynx; Larynx; Middle Aged; Mouth; Neoplasm Recurrence, Local; Nimorazole; Oropharynx; Papillomavirus Infections

2020